Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Braz. j. med. biol. res ; 29(5): 615-22, May 1996. graf
Article in English | LILACS | ID: lil-182544

ABSTRACT

Visceral leishmaniasis caused by Leishmania donovani, is a chroníc disease with a high mortality rate. This protozoan induces a serious dysfunction of the immune system characterized by suppression of the cellular response to parasite antigens. We provide evidence for the involvement of lipids in the immunological alterations of experimental leishmaniasis. Sera obtained from 60-day-infected hamsters present increased triglyceride levels. Inhibition of cell proliferation was observed when splenocytes from normal hamsters were stimulated with concanavalin A in the presence of 3 per cent infected hamster serum (IHS) (Control 50 + 3 (x 10(3)) Cpm; IHS 5 ñ 1 (X 10(3)) cpm). This inhibition was reversed by the addition of 5 mg/ml of delipidated bovine serum albumin (BSA) to the cultures (Control 65 ñ 1 (X 10(3)) cpm; IHS 75 ñ 3 (x 10(3)) cpm). The inhibitory effect of IHS was demonstrable only when added to the culture simultaneously with the mitogen. This effect was not as intense on fresh, pre-activated cells or on the CTLL-2 cells. This cell line stimulated by IL-2 in the presence of IHS is only marginally inhibited (about 20 per cent inhibition). The suppressor effect on CTLL-2 was not reversed by the addition of increasing doses of IL-2 (up to 100 U/ml) to cultures. The inhibition of the proliferative response of the CTLL-2 cells caused by IHS was also reversed by the addition of delipidated BSA. Our data suggest a role for fatty acids in the infected hamster serum-induced suppression of normal or L. donovani-infected cell proliferation.


Subject(s)
Animals , Female , Cricetinae , Humans , Cells, Cultured , Concanavalin A/pharmacology , Interleukin-2/pharmacology , Leishmania donovani/drug effects , Leishmaniasis, Visceral/chemically induced , Serum Albumin, Bovine/pharmacokinetics , Spleen , Suppressor Factors, Immunologic/blood , Interleukin-2/blood , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/immunology , Mesocricetus , Mitogens/pharmacology , Mitosis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL